1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ASB3 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA KLHL18 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA RP11-385J1.3 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA EFS CTRPv2 pan-cancer AAC 0.11 0.002
mRNA ZNF607 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA DGKB CTRPv2 pan-cancer AAC 0.11 0.002
mRNA DEFA6 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA SIX5 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA GBX1 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA JAKMIP1 CTRPv2 pan-cancer AAC 0.11 0.002
Download CSV